Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2009/091/000590
CTRI/2009/091/000590
Recruiting
Phase 1

Stem cell therapy- Cellular Cardio myoplasty for patients with severe ventricular dysfunction

Frontier Lifeline PvtLtd0 sites90 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Frontier Lifeline PvtLtd
Enrollment
90
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Frontier Lifeline PvtLtd

Eligibility Criteria

Inclusion Criteria

  • •Patients aged between 0 to 60 years presenting with Dilated Cardiomyopathy or coronary artery disease (CAD) are enrolled. Patients with ventricular ejection fraction (LVEF) less than 35% are eligible for enrollement.

Exclusion Criteria

  • •1\. Sustained ventricular tachycardia in a 24 hour ECG.
  • •2\. Chronic atrial fibrillation.
  • •3\. Less than 6 months since last episode of cerebral
  • •infarction.
  • •4\. Less than 6 months since last coronary angioplasty or
  • •less than 3 months since last bypass surgery.
  • •5\. Patients with unstable angina, with a treatment rating
  • •of 3 in the Braunwald system, but a severity of III and a
  • •clinical rating of B or C.
  • •6\. Presence of left ventricular thrombus by

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Intramyocardial Application of Stem Cells in combination with transmyocardial Laser Revascularisation (TMLR) in CABG Patients - INSTEM-TrialOther forms of chronic ischaemic heart diseaseMedDRA version: 70Level: LLTClassification code 10032058
EUCTR2005-004051-35-DEniversity Hospital Düsseldorf
Completed
Not Applicable
INtramyocardial application of STEM cells in combination with transmyocardial laser revascularisation in coronary artery bypass graft patientsCoronary artery bypass graftCirculatory System
ISRCTN49998633Heinrich-Heine-University (Germany)40
Active, not recruiting
Not Applicable
Cell therapy for cardiac repair through mobilization of hematopoietic stem cells and endothelial progenitors in patients with chronic ischemic cardiomyopathy. - NA
EUCTR2004-004545-18-BECHU Sart Tilman24
Completed
Phase 2
Allogeneic Stem Cell Therapy in Heart FailureHeart Failure
NCT03092284JKastrup81
Active, not recruiting
Phase 1
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-002929-19-DEDepartment of Cardiology, Rigshospitalet139